Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
– First Dosing with Norovirus GII.4 Oral Tablet Vaccine Scheduled for Week of March 18 – SOUTH SAN FRANCISCO, Calif.–(BUSINESS…
Pharmaceuticals, Biotechnology and Life Sciences
– First Dosing with Norovirus GII.4 Oral Tablet Vaccine Scheduled for Week of March 18 – SOUTH SAN FRANCISCO, Calif.–(BUSINESS…
Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY)…
DUBLIN–(BUSINESS WIRE)–The “Acute Myeloid Leukemia Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
— Declared development candidate in first targeted conditioning program — — Phase 1 study for first-line stem cell mobilization program…
Support Reinforces Company’s Commitment to Tackling This Deadly Disease SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a leading genomics…
ANDERNACH, Germany & BALLERUP, Denmark–(BUSINESS WIRE)–LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma…
WASHINGTON–(BUSINESS WIRE)–The Consumer Healthcare Products Association (CHPA) concluded their 2019 Annual Executive Conference, held from March 17-19, at the Boca…
Next-generation commercial data warehouse speeds implementation and automatically syncs with most important data sources PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/cloud?src=hash" target="_blank"gt;#cloudlt;/agt;–Veeva Systems…
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) today reported its financial results…
DCVAC/OvCa decreased the risk of death in second line treatment of ovarian cancer by 62% Overall survival (OS) increased significantly by…